Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
Titulaer MJ, McCracken L, et al.
Lancet Neurology; London 12.2 (Feb 2013): 157-65.
Anti-NMDA receptor encephalitis is an autoimmune disorder in which the use of immunotherapy and the long-term outcome have not been defined. We aimed to assess the presentation of the disease, the spectrum of symptoms, immunotherapies used, timing of improvement, and long-term outcome.
– Abstract from ncbi.nlm.nih.gov